Mechanisms of resistance to active state selective tri-complex RAS inhibitorsBen Sang, Piro Lito, Antonio Cuevas-Navarro et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 10
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Sumit Kar et al.|Molecular Cancer Therapeutics|2025Cited by 1